Read + Share
Plesa A, Roumier C, Gutrin J, Larcher MV, et al. Measurable residual disease including AML leukemia stem cell flow evaluation of
CPX-351 therapy by multi-parameter flow cytometry. Leuk Res 2021;111:106673.
PMID: 34364023
|
 |
|
Plesa A, Roumier C, Gutrin J, Larcher MV, et al. Measurable residual disease including AML leukemia stem cell flow evaluation of
CPX-351 therapy by multi-parameter flow cytometry. Leuk Res 2021;111:106673.
PMID: 34364023
|
|
|
|